SCHEMBL5774963

SCHEMBL5774963

OCc1cnoc1-c1ccc(Cl)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.38
KDM4E B2RXH2 4/20 0.34
F10 P00742 2/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 2/20 0.33
TRPV3 Q8NET8 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
PPARG P37231 1/20 0.33
KMT2A Q03164 1/20 0.33
NCOA2 Q15596 1/20 0.33
NCOA1 Q15788 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
HSD17B1 P14061 4/20 0.32
HSD17B2 P37059 3/20 0.32
SLC5A2 P31639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5777142 0.85 CYP2A6 (0.39) CYP2A6KDM4EF10ALDH1A1SMN1; SMN2
SCHEMBL5772111 0.84 F10 (0.37) CYP2A6KDM4EF10ALDH1A1SMN1; SMN2
SCHEMBL5773925 0.79 FFAR1 (0.44) KDM4EALDH1A1SMN1; SMN2HPGDMEN1
SCHEMBL5774934 0.75 RPS6KB2 (0.41) KDM4EALDH1A1SMN1; SMN2HPGDGAA
SCHEMBL5774711 0.69 RXRA (0.34) MEN1KMT2ATDO2
SCHEMBL7577573 0.69 NOTUM (0.55) KDM4EF10RAB9A
SCHEMBL5774717 0.69 AHR (0.41) MEN1LMNAKMT2ARAB9A
SCHEMBL4393304 0.69 ALDH1A1 (0.55) CYP2A6KDM4EALDH1A1SMN1; SMN2HPGD
SCHEMBL5772173 0.68 TDO2 (0.55) KDM4EALDH1A1SMN1; SMN2HPGDMEN1
SCHEMBL7502993 0.68 CYP2A6 (0.39) CYP2A6KDM4EF10ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR CYP2A6 170/4885KDM4E 3953/4885F10 1476/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 CYP2A6 180/4885KDM4E 3347/4885F10 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.